EyePoint Pharmaceuticals
EYPT
EYPT
45 hedge funds and large institutions have $104M invested in EyePoint Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+9
Holders Change %
+25%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
14
Reduced
3
Closed
10
Calls
$336K
Puts
$167K
Net Calls
+$169K
Net Calls Change
+$55K
Top Buyers
1 |
HighTower Advisors
Chicago,
Illinois
|
+$5.02M |
2 |
BlackRock
New York
|
+$2.04M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.38M |
4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$820K |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$549K |
Top Sellers
1 |
Renaissance Technologies
New York
|
-$702K |
2 |
![]()
JPMorgan Chase & Co
New York
|
-$513K |
3 |
Millennium Management
New York
|
-$278K |
4 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$164K |
5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$151K |